{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:03:19Z","timestamp":1782795799957,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cpcardiol.2024.102517","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T09:58:06Z","timestamp":1711101486000},"page":"102517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of Clinical Pharmacy anticoagulation service on Apixaban prescribing appropriateness in atrial fibrillation in Saudi Arabia"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8185-2445","authenticated-orcid":false,"given":"Elkholy","family":"Emad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elshammaa","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bajnaid","family":"Eshtyag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aboul-Enein","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalaby","family":"Ghada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102517_bib0001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/phar.2350","article-title":"Oral anticoagulant prescription trends, profile use, and determinants of adherence in patients with atrial fibrillation","volume":"40","author":"Perreault","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102517_bib0002","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/bcp.14264","article-title":"Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions","volume":"86","author":"Zhang","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102517_bib0003","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102517_bib0004","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jac5.1503","article-title":"Impact of a pharmacist-to-dose direct oral anticoagulant protocol on medication errors at an academic medical center","volume":"4","author":"Willeford","year":"2021","journal-title":"JACCP J American College Clinical Pharmacy"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102517_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/8755122516672693","article-title":"Pharmacist interventions regarding the appropriateness of apixaban, rivaroxaban, dabigatran, and warfarin in a university-affiliated outpatient clinic","volume":"32","author":"Phillippe","year":"2016","journal-title":"J Pharmacy Techn"},{"key":"10.1016\/j.cpcardiol.2024.102517_bib0006","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/IJGM.S260813","article-title":"Real-world analysis of potential pharmacokinetic and pharmacodynamic drug interactions with apixaban in patients with non-valvular atrial fibrillation","volume":"13","author":"Badreldin","year":"2020","journal-title":"Int J Gen Med"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102517_bib0007","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","article-title":"Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct oral anticoagulants","volume":"76","author":"Camm","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102517_bib0008","doi-asserted-by":"crossref","DOI":"10.1186\/s40780-020-0157-z","article-title":"Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: A single-center retrospective cohort study","volume":"6","author":"Miyazaki","year":"2020","journal-title":"J Pharm Health Care Sci"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102517_bib0009","doi-asserted-by":"crossref","DOI":"10.1186\/s13584-019-0285-9","article-title":"Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program","volume":"8","author":"Perlman","year":"2019","journal-title":"Isr J Health Policy Res"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102517_bib0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2217\/cer-2019-0197","article-title":"The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation","volume":"9","author":"Fern\u00e1ndez","year":"2020","journal-title":"J Comp Eff Res"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102517_bib0011","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11239-020-02064-0","article-title":"The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring","volume":"50","author":"Jones","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102517_bib0012","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00228-021-03212-y","volume":"78","author":"al Rowily","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102517_bib0013","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/jamacardio.2016.1829","article-title":"Apixaban 5 mg twice daily and clinical outcomes in patients with atrial fibrillation and advanced age, low body weight, or high creatinine: A secondary analysis of a randomized clinical trial","volume":"1","author":"Alexander","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102517_bib0014","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/clc.22949","article-title":"Initial apixaban dosing in patients with atrial fibrillation","volume":"41","author":"Buchholz","year":"2018","journal-title":"Clin Cardiol"},{"issue":"13","key":"10.1016\/j.cpcardiol.2024.102517_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: A practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2024.102517_bib0016","doi-asserted-by":"crossref","unstructured":"Z. X. Zhang et al., \u201cQuality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions,\u201d 2020, 10.1111\/bcp.14264.","DOI":"10.1111\/bcp.14264"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102517_bib0017","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102517_bib0018","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: A systematic review and meta-analysis","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age Ageing"},{"issue":"24","key":"10.1016\/j.cpcardiol.2024.102517_bib0019","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.jacc.2016.09.966","article-title":"Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: The ORBIT-AF II registry","volume":"68","author":"Steinberg","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102517_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007633","article-title":"Frequency and outcomes of reduced dose Non-Vitamin K antagonist anticoagulants: Results from ORBIT-AF II (The outcomes registry for better informed treatment of atrial fibrillation II","volume":"7","author":"Steinberg","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102517_bib0021","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bcp.14127","article-title":"Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: A systematic review","volume":"86","author":"Santos","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102517_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014108","article-title":"Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: The sage-af study","volume":"9","author":"Sanghai","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102517_bib0023","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/europace\/eux316","article-title":"Inappropriate doses of direct oral anticoagulants in real-world clinical practice: Prevalence and associated factors. A subanalysis of the FANTASIIA registry","volume":"20","author":"Ortiz","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.cpcardiol.2024.102517_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01220","article-title":"Appropriateness of DOAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing","volume":"9","author":"Moudallel","year":"2018","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102517_bib0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0897190019828270","article-title":"Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation: insights from the veterans health administration","volume":"33","author":"Leef","year":"2020","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.cpcardiol.2024.102517_bib0026","unstructured":"K. Lavoie et al., \u201cInappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation.\u201d [Online]. Available: www.jafib.com."},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102517_bib0027","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jjcc.2019.07.007","article-title":"Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study","volume":"75","author":"Inoue","year":"2020","journal-title":"J Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102517_bib0028","doi-asserted-by":"crossref","DOI":"10.18549\/PharmPract.2019.4.1709","article-title":"Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation","volume":"17","author":"Gustafson","year":"2019","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.cpcardiol.2024.102517_bib0029","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajem.2020.07.061","article-title":"Incidence of prescription errors in patients discharged from the emergency department","volume":"46","author":"Gregory","year":"2021","journal-title":"American J Emerg Med"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624001567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624001567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T21:37:44Z","timestamp":1714513064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624001567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0146280624001567"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102517","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Clinical Pharmacy anticoagulation service on Apixaban prescribing appropriateness in atrial fibrillation in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102517"}}